7601 - 7610 of 8808 Results
Title
Year
- Evaluation of the Braak staging scheme for Parkinson's disease: Introduction to a panel presentation2010RESTRICTEDTitle: Evaluation of the Braak staging scheme for Parkinson's disease: Introduction to a panel presentationJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: S1Start Page: S76End Page: 7Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22783Citation Count: 21
-
OPENTitle: Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism‐like phenotype in miceJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 35Issue #: 18Start Page: 2008End Page: 2025Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.15252/embj.201593585Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5282834Citation Count: 64
-
OPENTitle: Subcellular and regional localization of mRNA translation in midbrain dopamine neuronsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 110208End Page: 110208Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2021.110208Best OA location URL: http://www.cell.com/article/S2211124721017125/pdfCitation Count: 46
-
OPENTitle: The effect of LRRK2 loss-of-function variants in humansJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 26Issue #: 6Start Page: 869End Page: 877Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41591-020-0893-5Best OA location URL: https://www.nature.com/articles/s41591-020-0893-5.pdfCitation Count: 103
-
OPENTitle: Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controlsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 89Issue #: 19Start Page: 1959End Page: 1969Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000004609Best OA location URL: https://n.neurology.org/content/neurology/89/19/1959.full.pdfCitation Count: 145
-
OPENTitle: Tackling underrepresentation to aid understanding of Parkinson’s disease: Progress and further opportunitiesJournal Name: Physiology NewsPublisher: The Physiological SocietyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.36866/pn.123.32Best OA location URL: https://static.physoc.org/app/uploads/2021/09/29101854/PN123_2709_WEB_FINAL.pdfCitation Count: 0
-
RESTRICTEDTitle: A new model to study cell-to-cell transfer of αSynuclein in vivoJournal Name: Biochemical and Biophysical Research CommunicationsPublisher: Elsevier BVVol: 503Issue #: 3Start Page: 1385End Page: 1393Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbrc.2018.07.053Best OA location URL: https://repositorio.uchile.cl/handle/2250/167629Citation Count: 8
-
OPENTitle: The Cooperative Health Research in South Tyrol (CHRIS) study: rationale, objectives, and preliminary resultsJournal Name: Journal of Translational MedicinePublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12967-015-0704-9Best OA location URL: https://translational-medicine.biomedcentral.com/counter/pdf/10.1186/s12967-015-0704-9Citation Count: 89
-
OPENTitle: Childhood Stiff-Person Syndrome Improved with RituximabJournal Name: Case Reports in NeurologyPublisher: S. Karger AGVol: 4Issue #: 2Start Page: 92End Page: 96Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000339446Best OA location URL: https://www.karger.com/Article/Pdf/339446Citation Count: 46
- Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease Patient2017RESTRICTEDTitle: Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease PatientJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 40Issue #: 5Start Page: 233End Page: 234Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000230Citation Count: 7